Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac and betamethasone periarticular infiltration in total knee arthroplasty
ChiCTR1900024571Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine, ketorolac and betamethasone in knee osteoarthritis (OA) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Function scales outcomes, Rest pain and 4 more. Started Jul 2019; status: recruiting.
02
Drugs
ropivacaineketorolacbetamethasone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900024571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024571.